Risk factors and glycation end products in patients with different forms of coronary heart disease and type 2 diabetes mellitus
Aim. To determine the levels of growth factors and glycation end products in patients with different forms of coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM). Subjects and methods. A total of 134 patients with CHD and T2DM, including 38 patients with non-ST-elevation acute coronary...
Main Authors: | E V Ivannikova, V Yu Kalashnikov, O M Smirnova, I V Kononenko, A B Kuznetsov, S A Terekhin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2015-10-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31809 |
Similar Items
-
The effect of fibroblast growth factors and advanced glycation end-products on the intima-media complex thickness in patients with coronary heart disease and type 2 diabetes
by: Ekaterina Vladimirovna Ivannikova, et al.
Published: (2014-07-01) -
Advanced glycation end products, a potential link between psoriasis and cardiovascular disease: A case–control study
by: Tulin Ergun, et al.
Published: (2019-01-01) -
Role of advanced glycation end products on vascular smooth muscle cells under diabetic atherosclerosis
by: Lin Mao, et al.
Published: (2022-08-01) -
bFGF and TGFbeta1 growth factors, inflammatory markers (IL-6, TNF-alpha, CRP) and advanced glycation end-products (AGE, RAGE) in patients with ischemic heart disease and type 2 diabetes mellitus
by: Ekaterina Vladimirovna Ivannikova, et al.
Published: (2013-09-01) -
Expression of advanced glycation end products and receptors in gingival tissues of patients with noninsulin-dependent diabetes mellitus-associated periodontitis
by: Ya-Han Chang, et al.
Published: (2023-04-01)